Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors

MONDAY, Dec. 12, 2022 -- Nirmatrelvir plus ritonavir reduces the risk for hospitalization or death after an outpatient diagnosis of COVID-19 among older adults, according to a study published online Dec. 13 in the Annals of Internal Medicine. Scott...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news